CM
FLGT icon

Caption Management’s Fulgent Genetics FLGT Stock Holding History

Caption Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-147,500
Closed -$8.04M – 1616
2022
Q2 		$8.04M Buy
147,500
+22,500
+18% +$1.24M 0.11% 234
2022
Q1 		$7.8M Buy
+125,000
New +$8.23M 0.09% 294

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Caption Management's FLGT Position: Q4 2022 in Review

Caption Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 10,000 shares — an estimated $381K sold.

Caption Management first reported a position in FLGT in Q3 2022 and held it in 1 quarter. The position peaked at $381K in Q3 2022. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Caption Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 10,000 Fulgent Genetics shares in Q4 2022, an estimated $381K.
  • Caption Management first reported a position in Fulgent Genetics in Q3 2022 and held it in 1 quarter.
  • Caption Management's Fulgent Genetics position peaked at $381K in Q3 2022.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.